Latanoprost for Uncontrolled Glaucoma in a Compassionate Case Protocol
- 1 September 1997
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 124 (3) , 279-286
- https://doi.org/10.1016/s0002-9394(14)70819-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Reduction of Intraocular Pressure with Treatment of Latanoprost Once Daily in Patients with Normal-pressure GlaucomaOphthalmology, 1996
- A Six-month, Randomized, Double-masked Study Comparing Latanoprost with Timolol in Open-angle Glaucoma and Ocular HypertensionOphthalmology, 1996
- Comparison of Latanoprost and Timolol in Patients with Ocular Hypertension and GlaucomaOphthalmology, 1996
- Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol.British Journal of Ophthalmology, 1995
- Additive effect of latanoprost, a prostaglandin F2 alpha analogue, and timolol in patients with elevated intraocular pressure.British Journal of Ophthalmology, 1994
- The Effects on Aqueous Dynamics of PhXA41, a New Prostaglandin F2α Analogue, After Topical Application in Normal and Ocular Hypertensive Human EyesArchives of Ophthalmology (1950), 1993
- Intraocular Pressure-reducing Effect of PhXA41 in Ocular HypertensionOphthalmology, 1993
- Interaction of PhXA41, a New Prostaglandin Analogue, With PilocarpineArchives of Ophthalmology (1950), 1993
- Phenyl-substituted prostaglandins: potent and selective antiglaucoma agentsJournal of Medicinal Chemistry, 1993
- PhXA34--a prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension.British Journal of Ophthalmology, 1992